SynRxTherapeutics

SynRx Therapeutics, LLC (SynRxTherapeutics) is an innovative drug research and development company focused on the field of DNA damage repair. The company was co-founded by Professor Xiaochun Yu from the School of Life Sciences at Westlake University, and is based on the synthetic lethality strategy, concentrating on the development of precision cancer drugs. It has already initiated preclinical research for multiple original first-class new drugs, gaining recognition from industry experts both domestically and internationally, and has received various policy supports from the Zhejiang Provincial Government.